Quantcast

Latest Diabetes management Stories

Diabetes, Pre-Diabetes Cases Have Doubled Over Twenty Years
2014-04-16 03:00:23

Johns Hopkins Bloomberg School of Public Health Alarming Increases in Blacks, Hispanics and the Elderly; Obesity Partly to Blame Cases of diabetes and pre-diabetes in the United States have nearly doubled since 1988, suggests new research from the Johns Hopkins Bloomberg School of Public Health, with obesity apparently to blame for the surge. The researchers also found that the burden of the disease has not hit all groups equally, with alarming increases in diabetes in blacks, Hispanics...

2014-04-15 23:12:19

Avail is conducting a 6-week, Phase 2 randomized study to assess the safety, tolerability and pharmacodynamics of a new combination therapy administered to participants with type 2 diabetes mellitus. DeLand, FL (PRWEB) April 15, 2014 *To see if you qualify for this Diabetes Clinical Trial in DeLand, visit Avail Clinical Research on the web (http://www.availclinical.com) or contact us directly at (386) 785-2404. There is no cost to participate, no insurance required, and you may receive...

2014-04-15 16:27:56

LONDON, April 15, 2014 /PRNewswire/ -- GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved Tanzeum(TM) (albiglutide) for injection, for subcutaneous use, as a once-weekly treatment for type 2 diabetes. Tanzeum has been approved as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Albiglutide, a glucagon-like peptide-1 receptor agonist (GLP-1), is a biological product for the...

2014-04-14 12:34:30

New Abbott test could help physicians diagnose people in the U.S. who are unaware that they have diabetes, empowering them to control their disease ABBOTT PARK, Ill., April 14, 2014 /PRNewswire/ -- Abbott (NYSE: ABT) announced today that its new ARCHITECT Clinical Chemistry Hemoglobin A1c (HbA1c) test - which can aid physicians in diagnosing and monitoring diabetes and identifying people at risk for the disease - has received 510(k) clearance from the U.S. Food and Drug...

2014-04-14 12:32:44

Conference Call and Webcast at 8:30 a.m. Eastern Time THE WOODLANDS, Texas, April 14, 2014 /PRNewswire/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced today positive, top-line results in a Phase 2 clinical trial of LX4211 in type 1 diabetes, which achieved the primary endpoint of reducing mealtime insulin use as well as several secondary endpoints, including improved glycemic control. LX4211 is an oral, first-in-class, dual inhibitor of sodium glucose transporters 1 and 2...

2014-04-11 23:01:26

The Connecticut Health Council, an association of health sector leaders who work together to promote Connecticut as a national center of health excellence and to improve health care and wellness, will host ‘Innovation Takes on the Diabetes Pandemic’ featuring John L. Brooks, III, President and Chief Executive Officer of the Joslin Diabetes Center on Thursday, April 17th from 7:30-9:30a.m. at the New Haven Lawn Club, 193 Whitney Avenue in New Haven, Conn. Hartford, Conn. (PRWEB) April...

2014-04-11 23:00:14

"Cure Diabetes Naturally" book, developed by Jacob Swilling, promises to help people mange their blood sugar levels effectively. A full review on the site Vkool.com brings great news to people suffering from diabetes. Seattle, Wa (PRWEB) April 11, 2014 According to the review on Vkool.com, the "Cure Diabetes Naturally" book actually is effective in providing patients all the basic information they need to reduce high blood sugar and improve their health. In the...

2014-04-10 23:26:08

A New Opportunity for Advertisers to Reach Healthcare Professionals Focused on the Treatment and Management of Diabetes Ewing, NJ (PRWEB) April 10, 2014 eHealthcare Solutions (EHS) is proud to announce Diabetes In Control (http://www.diabetesincontrol.com), which was recently acquired by HIPER, LLC, has signed a multi-year exclusive site representation agreement as a partner in its Healthcare Professional (HCP) network. Diabetes in Control is an online resource for medical professionals...

2014-04-10 23:25:43

RnRMarketResearch.com adds latest report on “Insulin Delivery Devices Market to 2019 – Simplified Pump Solutions and Low Cost Pens Represent Distinct Regional Growth Drivers” to its store. Purchase a copy of this report at http://www.rnrmarketresearch.com/contacts/purchase?rname=165983. Dallas, TX (PRWEB) April 10, 2014 Global Insulin Delivery Devices Market to See Significant Growth During the Forecast Period The global insulin delivery devices market was valued at $8.8 billion in...

2014-04-10 23:23:58

ResearchMoz.us include new market research report "Type 2 Diabetes - Pipeline Review, H1 2014" to its huge collection of research reports. Albany, New York (PRWEB) April 10, 2014 Global Markets Direct’s, ‘Type 2 Diabetes - Pipeline Review, H1 2014’, provides an overview of the Type 2 Diabetes’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Type 2 Diabetes, complete with comparative analysis at various stages,...


Latest Diabetes management Reference Libraries

Diabetes Care
2012-05-12 21:41:27

Diabetes Care is a peer-reviewed medical journal established in 1978 and published monthly by the American Diabetes Association. It covers research in the following five categories: clinical care/education/nutrition/psychosocial research; epidemiology/health services research; emerging treatments and technologies; pathophysiology/complications; and cardiovascular and metabolic risk. The journal also publishes clinically relevant review articles, letters to the editor, and commentaries....

More Articles (1 articles) »
Word of the Day
bellycheer
  • Good cheer; viands.
  • To revel; to feast.
The word 'bellycheer' may come from 'belle cheer', "good cheer".
Related